CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 166 enrolled
Drug / intervention
intravenous oxytocin +1 moredrug
Likely dose
intravenous oxytocin 30 unitsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02083809
NCT02083809N/ACompleted

A Randomized Double-blinded Controlled Trial Comparing Dilation and Evacuation Outcomes With and Without Oxytocin Use

University of Hawaii·interventional·Posted Mar 11, 2014·Updated Nov 27, 2020

In Brief

A clinical study evaluating intravenous oxytocin and Intravenous Fluids and Electrolytes for Abortion and 3 related conditions. Completed, enrolled 166 participants across 2 sites.

Detailed Summary

Currently, there is very little research to identify ways to decrease blood loss during D\&E (dilation and evacuation) procedures. The objective is to determine whether routine use of intravenous oxytocin will improve bleeding outcomes at the time of D\&E at 18-24-weeks gestation. To evaluate the hypothesis, investigators will perform a randomized, double-blinded, placebo-controlled trial. The patient will be followed until discharged from the postoperative care unit during which time patient satisfaction, pain score and postoperative bleeding will be assessed.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMar 11, 2014
Enrollment StartOct 1, 2014
Primary CompletionFeb 1, 2018
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 12.3 years ago

Interventions

intravenous oxytocindrug

30 units of oxytocin added to 500ml of inert IV fluid (saline, lactated ringer)

Intravenous Fluids and Electrolytesdrug

500 ml of inert IV fluid